Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Aedimin Tablet PR

Prescription Icon
Prescription Required

Marketer

Aadi Health Care

Salt Composition

Metformin (1000mg)

Overview Aedimin Tablet PR

Diabex PR tablets are indicated for managing type 2 diabetes mellitus, effectively regulating blood glucose and mitigating associated complications. This medication also addresses Polycystic Ovary Syndrome (PCOS) in women. For optimal absorption and to minimize gastrointestinal distress, Diabex PR should be administered with food, consistently at the same time daily. Discontinuation should only occur under medical supervision. Maintaining a healthy lifestyle, including adhering to prescribed dietary and exercise regimens, significantly contributes to diabetes management. Commonly reported adverse effects include diarrhea, nausea, vomiting, gas, fatigue, dyspepsia, stomach upset, headache, and anorexia. Concurrent use with other antidiabetic medications, alcohol consumption, or missed meals may lead to hypoglycemia (low blood sugar); diligent blood glucose monitoring is essential. Prior to commencing treatment, patients with pre-existing kidney, liver, or heart conditions, as well as pregnant or breastfeeding individuals, must consult their physician. Renal function assessment is routinely conducted before treatment initiation. Excessive alcohol consumption should be avoided due to the potential for increased side effect risk.

Uses of Aedimin Tablet PR

Management of type 2 diabetes and polycystic ovary syndrome

Major Benefits of Aedimin Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Take Aedimin Tablet PR with meals.

Common Side effects of Aedimin Tablet PR:

  • Diarrhea
  • Headache
  • Vomiting
  • Nausea
  • Flatulence
  • Abdominal discomfort
  • Weakness

How to use Aedimin Tablet PR:

Follow your doctor's instructions or the package directions. Take Aedimin Tablet PR with a meal.

How Aedimin Tablet PR works:

Aedimin PR tablets, a biguanide class antidiabetic agent, reduce blood sugar levels through a triple mechanism: diminished hepatic glucose output, slowed intestinal glucose uptake, and enhanced insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Aedimin Tablet PR is inadvisable.

PregnancyPregnancySAFE IF PRESCRIBED

Use of Aedimin Tablet PR during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, data from human studies remain scarce.

Breast feedingBreast feedingCAUTION

Use of Aedimin Tablet PR requires careful consideration while breastfeeding. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Aedimin Tablet PR cautiously, potentially requiring dosage modification. Physician consultation is advised. Aedimin Tablet PR is contraindicated in individuals with severe kidney disease.

LiverLiverUNSAFE

Individuals with liver conditions should likely refrain from using Aedimin Tablet PR due to potential safety concerns. Medical advice is recommended.

What if you forget to take Aedimin Tablet PR :

Should you forget to take a dose of Aedimin Tablet PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Aedimin Tablet PR

LabelValue
Type of Compound Guanidine-based medication
Addictive None.
Medication Category Medication for diabetes

FAQs on Aedimin Tablet PR

Individuals with type 2 diabetes exhibit impaired responsiveness to endogenous insulin. Consequently, blood glucose levels rise. Aedimin Tablet PR employs a multifaceted approach to lower elevated blood sugar. This involves reducing hepatic glucose production, diminishing intestinal glucose absorption postprandially, and enhancing insulin sensitivity in tissues. These actions facilitate improved glucose uptake from the bloodstream and optimized utilization of naturally produced insulin.
Indeed, studies indicate Aedimin Tablet PR can lead to weight reduction in overweight or obese patients. This weight loss effect may also be observed, albeit less pronounced, in overweight or obese individuals predisposed to diabetes. Furthermore, individuals with insulin resistance or sensitivity may experience similar results. However, self-initiating Aedimin Tablet PR for weight management is strongly discouraged. Always seek medical advice before commencing treatment.
Aedimin Tablet PR is an initial treatment option for individuals with elevated blood glucose. This medication manages blood sugar by enhancing the body's insulin sensitivity, reducing hepatic glucose production, and minimizing intestinal glucose absorption. Unlike other oral hypoglycemics, Aedimin Tablet PR, when used monotherapy, infrequently leads to hypoglycemia due to its mechanism preventing excessive insulin release. Beyond glycemic control, it also aids in weight management.
Aedimin Tablet PR is generally well-received and doesn't typically induce drowsiness. Infrequently, however, it may lead to sleep disturbances or insomnia. Excessive sleepiness can be a symptom of a severe adverse reaction known as lactic acidosis, especially in individuals with impaired kidney function. Consult your physician if fatigue or somnolence develops during Aedimin Tablet PR treatment.
Administer Aedimin Tablet PR orally, with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily regimens, take with breakfast. Twice-daily prescriptions should be divided, one dose with breakfast, the other with dinner. Three times daily, distribute doses with breakfast, lunch, and dinner. Consuming Aedimin Tablet PR with food mitigates potential gastrointestinal distress including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their body's own insulin. This results in elevated blood glucose levels. Aedimin Tablet PR employs a multi-faceted approach to lower these high blood sugar levels. It reduces glucose generation by the liver, diminishes glucose absorption from the intestines following meals, and enhances the insulin sensitivity of bodily tissues and muscles. This combined action facilitates improved glucose uptake from the bloodstream. The tablet also promotes a more effective response to naturally produced insulin.
Individuals overweight or obese have experienced weight reduction while using Aedimin Tablet PR. This medication may also modestly reduce weight in overweight or obese individuals predisposed to diabetes. Furthermore, weight loss has been observed in patients with insulin sensitivity or resistance. However, self-initiation of Aedimin Tablet PR for weight loss is inadvisable; physician consultation is necessary.
Aedimin Tablet PR is an initial treatment option for patients exhibiting hyperglycemia. This medication facilitates blood glucose regulation by enhancing the body's insulin responsiveness, reducing hepatic glucose production, and diminishing intestinal glucose absorption. Differing from other oral antidiabetic agents, Aedimin Tablet PR, when used monotherapeutically, infrequently leads to hypoglycemia due to its inhibition of excessive pancreatic insulin secretion. Beyond its efficacy in glycemic control, it also aids in managing weight increase.
Aedimin Tablet PR generally does not induce drowsiness and is typically well-received. Infrequently, however, Aedimin Tablet PR use may result in sleep disturbances and insomnia. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician if fatigue or sleepiness develops during Aedimin Tablet PR treatment.
Administer Aedimin Tablet PR with or following a meal. Avoid crushing or chewing the tablets; ingest them whole with water. For once-daily prescriptions, morning administration with breakfast is recommended. For twice-daily prescriptions, divide doses between morning and evening meals. If three doses are prescribed, distribute them with breakfast, lunch, and dinner. Consuming Aedimin Tablet PR with food mitigates potential gastrointestinal distress such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their own insulin. This results in elevated blood glucose levels. Aedimin Tablet PR works through multiple mechanisms to lower these high blood sugar levels. It reduces glucose synthesis in the liver, diminishes glucose absorption from the intestines following meals, and enhances insulin sensitivity in tissues and organs. Consequently, glucose uptake from the bloodstream improves, and the body's natural insulin response is augmented.
Weight loss has been observed in overweight and obese individuals using Aedimin Tablet PR. This effect may also be seen, albeit modestly, in overweight and obese patients predisposed to diabetes. Similarly, insulin-resistant or insulin-sensitive patients might experience weight reduction. However, self-medicating with Aedimin Tablet PR for weight loss is strongly discouraged; physician consultation is essential.
Aedimin Tablet PR is an initial treatment option for individuals with elevated blood glucose. This medication manages blood sugar by enhancing the body's insulin response, reducing hepatic glucose production, and diminishing intestinal glucose absorption. In contrast to other oral hypoglycemics, Aedimin Tablet PR monotherapy infrequently leads to hypoglycemia due to its mechanism of preventing excessive insulin release from the pancreas. Beyond glycemic control, it also aids in weight management.
Aedimin Tablet PR is generally well-received and doesn't typically induce drowsiness. Nevertheless, in rare instances, it can lead to sleep disturbances or insomnia. Excessive sleepiness might indicate a severe adverse reaction known as lactic acidosis, especially prevalent in individuals with impaired kidney function. Consult your physician if fatigue or drowsiness develops during Aedimin Tablet PR treatment.
Administer Aedimin Tablet PR orally, with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily regimens, take with breakfast. Twice-daily prescriptions should be divided, one dose with breakfast and one with dinner. Three times daily, distribute doses with breakfast, lunch, and dinner. Concurrent ingestion with food minimizes gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Aedimin Tablet PR
29
MRP 34
13% off